What is the global market size of Orthopedic Implants Market?

Microbubbles/Ultrasound Contrast Agents Market size was valued at USD 1.8 billion in 2021 and is poised to grow from USD 1.87 billion in 2022 to USD 2.56 billion by 2030, growing at a CAGR of 4% in the forecast period (2023-2030).

Global Microbubbles/Ultrasound Contrast Agents Market

Microbubbles/Ultrasound Contrast Agents Market Size, Share, Growth Analysis, By Disease Area(Cardio-vascular, Abdominal, Others), By Application(Diagnostic imaging, Drug delivery, Others), By End Use(Diagnostic centers, Hospitals, Others), By Region(North America, Europe, Asia-Pacific, Latin America), By Region - Industry Forecast 2025-2032

Report ID: SQMIG35H2055 | Region: Global | Published Date: April, 2024
Pages: 219 | Tables: 119 | Figures: 78

Microbubbles/Ultrasound Contrast Agents Market Regional Insights

Europe is anticipated to be dominant in the microbubbles/ultrasound contrast agents market. The growth of the global microbubbles/ultrasound contrast agents market in North America and Europe is driven by an increase in the geriatric population, an increase in the incidence and prevalence of chronic diseases, a well-established healthcare infrastructure, an increase in the cost of research and development, an increase in the adoption of advanced technologies, and higher healthcare expenditure in the regions. India and China are expected to dominate the microbubbles/ultrasound contrast agents market in Asia-Pacific during the forecast period due to their large patient bases, rising awareness, increased government efforts to improve public health, and developed healthcare infrastructure. Due to the increasing investments made by market participants in these regions, it is anticipated that the global market for microbubbles/ultrasound contrast agents will expand during the forecast period.

Microbubbles/Ultrasound Contrast Agents Market Report Snapshots

License Type Top market research company in USA

File Type

$5,300

BUY NOW GET FREE SAMPLE

Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Microbubbles/Ultrasound Contrast Agents Market size was valued at USD 1.94 Billion in 2023 and is poised to grow from USD 2.02 Billion in 2024 to USD 2.77 Billion by 2032, growing at a CAGR of 4.00% during the forecast period (2025-2032).

The major players covered in the microbubble contrast media market , while GE Healthcare is committed to providing a broad comprehensive portfolio of CM products that help meet your patient and procedural needs across a multitude of modalities. 'General Electric Company', 'Bracco Imaging S.p.A.', 'Lantheus Holdings, Inc.', 'Daiichi Sankyo Company, Limited', 'Bayer AG', 'Fujifilm Holdings Corporation', 'Sanofi S.A.', 'Siemens Healthineers AG', 'Guerbet Group', 'nanoPET Pharma GmbH', 'MBI Co., Ltd.', 'Trivitron Healthcare', 'Unilife Corporation', 'PTW Freiburg GmbH', 'Esaote SpA', 'Mindray Medical International Limited', 'Samsung Electronics Co., Ltd.', 'Shimadzu Corporation', 'Philips Healthcare', 'Canon Medical Systems Corporation', 'In 2022, The University of Texas MD Anderson Cancer Center Researchers developed an ultrasound-guided cancer immunotherapy platform that generates systemic antitumor immunity and improves the therapeutic efficacy of immune checkpoint blockade. The findings from the preclinical study were published in Nature Nanotechnology.'

The use of microbubbles and ultrasound contrast agents in molecular imaging is further driven by the growing demand for targeted therapies and the need to monitor the status of the biomarker in the vascular endothelium. During the forecast period, the microbubbles/ultrasound contrast agents market is anticipated to expand due to advancements in ultrasound technologies, an increase in the demand for targeted diagnostic tools, the advantages of microbubbles/ultrasound contrast agents over traditional diagnostic tools, and an increase in the prevalence of chronic diseases.

In cardiology and radiology, microbubbles are utilized as blood-pool agents for contrast ultrasound imaging. They are now being recognized for their potential as targeted agents for molecular imaging. Using ligand molecules that bind to disease-related molecular markers, microbubbles can be made functional. Monitoring the biomarker status of vascular endothelium, visualizing tumor vasculature, and imaging inflammation and ischemia-reperfusion injury zones and thrombi are all potential clinical applications of molecular imaging with microbubble-based ultrasound contrast agents.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Microbubbles/Ultrasound Contrast Agents Market Regional Insights

Microbubbles/Ultrasound Contrast Agents Market Report Snapshots

Want to customize this report?

FAQs

What is the global market size of Microbubbles/Ultrasound Contrast Agents Market?

Who are the key vendors in the Microbubbles/Ultrasound Contrast Agents Market?

What is the key driver of Microbubbles/Ultrasound Contrast Agents Market?

What is the key market trend for Microbubbles/Ultrasound Contrast Agents Market?

Which region accounted for the largest share in Microbubbles/Ultrasound Contrast Agents Market?

Request Free Customization

Related Reports

Feedback From Our Clients

$5,300